I agree that this site is using cookies. You can find further informations here.
X
Doi, Toshihiko
469  results:
Search for persons X
?
1

A phase 1/1b, open-label, dose-escalation study of PD-1 inh..:

Yamamoto, Noboru ; Kuboki, Yasutoshi ; Harano, Kenichi...
Investigational New Drugs.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

LEAP-014: first-line lenvatinib + pembrolizumab + chemother..:

Sun, Jong-Mu ; Adenis, Antoine ; C Enzinger, Peter...
Future Oncology.  , 2024
Link: https://doi.org/10.2217/..
 
?
3

A molecular glue RBM39-degrader induces synthetic lethality..:

Kohsaka, Shinji ; Yagishita, Shigehiro ; Shirai, Yukina...
npj Precision Oncology.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
4

PD‐1 inhibition with retifanlimab and/or arginase inhibitio..:

Kuboki, Yasutoshi ; Koyama, Takafumi ; Matsubara, Nobuaki...
Cancer Medicine.  13 (2024)  8 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
5

First-line pembrolizumab plus chemotherapy for advanced/met..:

Kato, Ken ; Kojima, Takashi ; Hara, Hiroki...
Esophagus.  21 (2024)  3 - p. 306-318 , 2024
Link: https://doi.org/10.1007/..
 
?
6

KEYNOTE-434 part B: A phase 1 study evaluating the combinat..:

Yamamoto, Noboru ; Satouchi, Miyako ; Doi, Toshihiko...
Investigational New Drugs.  42 (2024)  3 - p. 261-271 , 2024
Link: https://doi.org/10.1007/..
 
?
7

A first-in-human phase I study of TAS-117, an allosteric AK..:

Doi, Toshihiko ; Takahashi, Shunji ; Aoki, Daisuke...
Cancer Chemotherapy and Pharmacology.  93 (2024)  6 - p. 605-616 , 2024
Link: https://doi.org/10.1007/..
 
?
8

Health-related quality-of-life analysis from KEYNOTE-590: p..:

Mansoor, Wasat ; Joo, Seongjung ; Norquist, Josephine M...
The Oncologist.  , 2024
Link: https://doi.org/10.1093/..
 
?
9

Current status of and future prospects for the treatment of..:

Naito, Yoichi ; Nishida, Toshirou ; Doi, Toshihiko
Gastric Cancer.  26 (2023)  3 - p. 339-351 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Pimitespib for the Treatment of Advanced Gastrointestinal S..:

Doi, Toshihiko ; Yamamoto, Noboru ; Ohkubo, Shuichi
Future Oncology.  20 (2023)  9 - p. 507-519 , 2023
Link: https://doi.org/10.2217/..
 
?
11

Quantitative Analysis of the Concentration of Trifluridine ..:

Koganemaru, Shigehiro ; Fuchigami, Hirobumi ; Yamashita, Hiroki...
Clinical Pharmacology & Therapeutics.  115 (2023)  1 - p. 62-70 , 2023
Link: https://doi.org/10.1002/..
 
?
12

Pharmacokinetics and immunogenicity of eftozanermin alfa in..:

Biesdorf, Carla ; Guan, Xiaowen ; Siddani, Satya R....
Cancer Chemotherapy and Pharmacology.  , 2023
Link: https://doi.org/10.1007/..
 
?
13

Body weight loss as a prognostic and predictive factor in p..:

Ghidini, Michele ; Hochster, Howard ; Doi, Toshihiko...
Gastric Cancer.  26 (2023)  4 - p. 626-637 , 2023
Link: https://doi.org/10.1007/..
 
?
14

First‐in‐human study of E7130 (a tumor microenvironment‐ame..:

Doi, Toshihiko ; Matsubara, Nobuaki ; Naito, Yoichi...
Cancer.  129 (2023)  15 - p. 2348-2359 , 2023
Link: https://doi.org/10.1002/..
 
?
15

p70S6K/Akt dual inhibitor DIACC3010 is efficacious in precl..:

Fukuoka, Shota ; Koga, Yoshikatsu ; Yamauchi, Mayumi...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
1-15